ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING CONCOMITANT RADIOTHERAPY WITH TEMOZOLOMIDE USING FET PET IN PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
Stetter, I [1 ,2 ]
Werner, J. [1 ,2 ]
Wollring, M. [1 ,2 ]
Ceccon, G. [2 ]
Lohmann, P. [3 ,4 ]
Stoffels, G. [3 ]
Mottaghy, F. M. [4 ]
Fink, G. R. [1 ,2 ,3 ]
Langen, K. [3 ,4 ]
Galldiks, N. [1 ,2 ]
机构：
[1] Univ Hosp Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Hosp Cologne, Cologne, Germany
[3] Res Ctr Juelich, INM 4, Inst Neurosci & Med INM 3, Julich, Germany
[4] RWTH Univ Hosp Aachen, Dept Nucl Med, Aachen, Germany
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae144.318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING TEMOZOLOMIDE CHEMORADIATION USING FET PET INCLUDING RADIOMICS IN PATIENTS WITH GLIOBLASTOMA
    Stetter, Isabelle
    Werner, Jan-Michael
    Wollring, Michael
    Ceccon, Garry
    Lohmann, Philipp
    Ciantar, Keith George
    Stoffels, Gabriele
    Mottaghy, Felix M.
    Fink, Gereon R.
    Langen, Karl-Josef
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2024, 26
  • [2] Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma
    Christopher A. Barker
    Maria Chang
    Joanne F. Chou
    Zhigang Zhang
    Kathryn Beal
    Philip H. Gutin
    Fabio M. Iwamoto
    Journal of Neuro-Oncology, 2012, 109 : 391 - 397
  • [3] Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma
    Barker, Christopher A.
    Chang, Maria
    Chou, Joanne F.
    Zhang, Zhigang
    Beal, Kathryn
    Gutin, Philip H.
    Iwamoto, Fabio M.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 391 - 397
  • [4] EARLY INITIATION OF RADIOTHERAPY PLUS CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) AND OVERALL SURVIVAL (OS) IN GLIOBLASTOMA (GBM) PATIENTS
    Roessler, K.
    Muxel, M.
    Zachenhofer, I.
    Maier, R.
    DeVries, A.
    NEURO-ONCOLOGY, 2010, 12 : 48 - 48
  • [5] DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET
    Werner, Jan-Michael
    Ceccon, Garry
    Weller, Johannes
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena
    Schaefer, Niklas
    Stoffels, Gabriele
    Kabbasch, Christoph
    Baues, Christian
    Marnitz, Simone
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2020, 22 : 152 - 153
  • [6] Survival analysis following the addition of temozolomide to surgery and radiotherapy in patients with glioblastoma multiforme
    Gil-Salú, JL
    Román, P
    Benítez, E
    Maestro, E
    Pérez-Requena, J
    López-Escobar, M
    NEUROCIRUGIA, 2004, 15 (02): : 144 - 150
  • [7] EXTENT OF GLIOBLASTOMA INVASION PREDICTS OVERALL SURVIVAL FOLLOWING UPFRONT RADIOTHERAPY CONCURRENT WITH TEMOZOLOMIDE
    Massey, Susan Christine
    White, Haylye
    Rayfield, Corbin
    Rickertsen, Cassandra R.
    Clark-Swanson, Kamala
    Whitmire, Scott
    Johnston, Sandra K.
    Porter, Alyx
    Mrugala, Maciej
    Bendok, Bernard
    Swanson, Kristin R.
    NEURO-ONCOLOGY, 2017, 19 : 262 - 262
  • [8] OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Swaminath, A.
    McMillan, W.
    McCarter, H.
    Hirte, H.
    Whitton, A.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S52 - S52
  • [9] Survival in Patients Receiving Radiotherapy Plus Concomitant and Adjuvant Temozolomide (RCAT) for Glioblastoma (GBM)
    Hargreaves, S. J.
    Williams, M.
    Liu, Z.
    Michalarea, V.
    Woolf, D.
    Wilson, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S281 - S282
  • [10] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, Jan-Michael
    Wollring, Michael M.
    Tscherpel, Caroline
    Rosen, Elena K.
    Ceccon, Garry
    Stetter, Isabelle
    Lohmann, Philipp
    Weller, Johannes
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Mottaghy, Felix M.
    Goldbrunner, Roland
    Herrlinger, Ulrich
    Fink, Gereon R.
    Langen, Karl-Josef
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2024, 26
12345